1887
  1. Home
  2. Eurosurveillance
  3. Volume 31, Issue 13, 02/Apr/2026
  4. Article
Research Open Access
Like 0
Download

Abstract

BACKGROUND

In South Korea, norovirus outbreaks have been predominantly attributed to the GII.4 genotype; however, since mid-2024, strains harbouring the GII.17 genotype are being detected more frequently, raising concerns about a potential shift in the dominant circulating strain and resulting public health implications.

AIM

We aimed to analyse the nt sequences of the gene encoding the viral protein 1 (VP1), the major capsid protein, of the GII.17 norovirus strains detected in South Korea in 2024, compare them with the corresponding nt sequences of the GII.17 Kawasaki 2014 lineage strains and evaluate whether GII.17 has the potential to replace the long-dominant GII.4 genotype.

METHODS

We obtained 11 complete VP1 sequences from stool specimens collected across six regions in South Korea (Busan, Daejeon, Gangwon-do, Gyeongsangbuk-do, Incheon, Jeollanam-do) in 2024 and compared them with the VP1 sequence of the reference strain (GII.17 Kawasaki 2014) to identify genetic changes.

RESULTS

Key amino acid substitutions (R299P, N378D and K388R) were identified in the P2 domain of the VP1, which is a major antigenic site. Notably, N378D corresponds to D374 in the GII.4 genotype, which is a position involved in histo-blood group antigen (HBGA) binding, and K388R, adjacent to other antigenic sites, may alter the surface charge of the capsid.

CONCLUSION

The data provide molecular evidence that the emerging GII.17 strain in South Korea may evade the host immune surveillance machinery and exhibit altered receptor binding, underscoring the public health threat posed by this strain and the need for enhanced genomic surveillance and effective vaccine development.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.13.2500372
2026-04-02
2026-04-21
/content/10.2807/1560-7917.ES.2026.31.13.2500372
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/13/eurosurv-31-13-4.html?itemId=/content/10.2807/1560-7917.ES.2026.31.13.2500372&mimeType=html&fmt=ahah

References

  1. Pringle K, Lopman B, Vega E, Vinje J, Parashar UD, Hall AJ. Noroviruses: epidemiology, immunity and prospects for prevention. Future Microbiol. 2015;10(1):53-67.  https://doi.org/10.2217/fmb.14.102  PMID: 25598337 
  2. Chan MCW, Hu Y, Chen H, Podkolzin AT, Zaytseva EV, Komano J, et al. Global spread of norovirus GII.17 Kawasaki 308, 2014-2016. Emerg Infect Dis. 2017;23(8):1359-1354.  https://doi.org/10.3201/eid2308.161138  PMID: 28726618 
  3. Lu J, Sun L, Fang L, Yang F, Mo Y, Lao J, et al. Gastroenteritis outbreaks caused by norovirus GII.17, Guangdong Province, China, 2014-2015. Emerg Infect Dis. 2015;21(7):1240-2.  https://doi.org/10.3201/eid2107.150226  PMID: 26080037 
  4. Gao Z, Liu B, Huo D, Yan H, Jia L, Du Y, et al. Increased norovirus activity was associated with a novel norovirus GII.17 variant in Beijing, China during winter 2014-2015. BMC Infect Dis. 2015;15(1):574.  https://doi.org/10.1186/s12879-015-1315-z  PMID: 26678989 
  5. de Graaf M, van Beek J, Vennema H, Podkolzin AT, Hewitt J, Bucardo F, et al. Emergence of a novel GII.17 norovirus – End of the GII.4 era? Euro Surveill. 2015;20(26):21178.  https://doi.org/10.2807/1560-7917.ES2015.20.26.21178  PMID: 26159308 
  6. Chhabra P, Wong S, Niendorf S, Lederer I, Vennema H, Faber M, et al. Increased circulation of GII.17 noroviruses, six European countries and the United States, 2023 to 2024. Euro Surveill. 2024;29(39):2400625.  https://doi.org/10.2807/1560-7917.ES.2024.29.39.2400625  PMID: 39328162 
  7. Barclay L, Vinjé J. Increasing predominance of norovirus GII.17 over GII.4, United States, 2022-2025. Emerg Infect Dis. 2025;31(7):1471-3.  https://doi.org/10.3201/eid3107.250524  PMID: 40456181 
  8. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. Norovirus immunity and the great escape. PLoS Pathog. 2012;8(10):e1002921.  https://doi.org/10.1371/journal.ppat.1002921  PMID: 23093932 
  9. Lindesmith LC, Beltramello M, Donaldson EF, Corti D, Swanstrom J, Debbink K, et al. Immunogenetic mechanisms driving norovirus GII.4 antigenic variation. PLoS Pathog. 2012;8(5):e1002705.  https://doi.org/10.1371/journal.ppat.1002705  PMID: 22615565 
  10. Tan M, Jiang X. Histo-blood group antigens: a common niche for norovirus and rotavirus. Expert Rev Mol Med. 2014;16:e5.  https://doi.org/10.1017/erm.2014.2  PMID: 24606759 
  11. Matsushima Y, Ishikawa M, Shimizu T, Komane A, Kasuo S, Shinohara M, et al. Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill. 2015;20(26):21173.  https://doi.org/10.2807/1560-7917.ES2015.20.26.21173  PMID: 26159307 
  12. Lu J, Fang L, Zheng H, Lao J, Yang F, Sun L, et al. The evolution and transmission of epidemic GII.17 noroviruses. J Infect Dis. 2016;214(4):556-64.  https://doi.org/10.1093/infdis/jiw208  PMID: 27354370 
  13. Debbink K, Lindesmith LC, Baric RS. The state of norovirus vaccines. Clin Infect Dis. 2014;58(12):1746-52.  https://doi.org/10.1093/cid/ciu120  PMID: 24585561 
  14. Esposito S, Principi N. Norovirus vaccine: priorities for future research and development. Front Immunol. 2020;11:1383.  https://doi.org/10.3389/fimmu.2020.01383  PMID: 32733458 
  15. Cannon JL, Barclay L, Collins NR, Wikswo ME, Castro CJ, Magaña LC, et al. Genetic and epidemiologic trends of norovirus outbreaks in the United States from 2013 to 2016 demonstrated emergence of novel GII.4 recombinant viruses. J Clin Microbiol. 2017;55(7):2208-21.  https://doi.org/10.1128/JCM.00455-17  PMID: 28490488 
  16. Shanker S, Czakó R, Sapparapu G, Alvarado G, Viskovska M, Sankaran B, et al. Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody. Proc Natl Acad Sci USA. 2016;113(40):E5830-7.  https://doi.org/10.1073/pnas.1609990113  PMID: 27647885 
  17. Lindesmith LC, Donaldson EF, Lobue AD, Cannon JL, Zheng DP, Vinje J, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 2008;5(2):e31.  https://doi.org/10.1371/journal.pmed.0050031  PMID: 18271619 
  18. Chan MCW, Lee N, Hung TN, Kwok K, Cheung K, Tin EK, et al. Rapid emergence and predominance of a broadly recognizing and fast-evolving norovirus GII.17 variant in late 2014. Nat Commun. 2015;6(1):10061.  https://doi.org/10.1038/ncomms10061  PMID: 26625712 
  19. Kim H, Won YJ, Kang LH, Lee AR, Han JI, Suh CI, et al. Complete sequence analysis of human norovirus GII.17 detected in South Korea. Epidemiol Infect. 2019;147:e203.  https://doi.org/10.1017/S0950268819000943  PMID: 31364537 
Molecular genetic characterisation of norovirus GII.17 strains circulating in South Korea in 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Yunhee+Jo&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Jo Yunhee</a>, <a href="/search?value1=Minji+Lee&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lee Minji</a>, <a href="/search?value1=Deog-Yong+Lee&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Lee Deog-Yong</a>, <a href="/search?value1=Myung-Guk+Han&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Han Myung-Guk</a>, <a href="/search?value1=Sun-Whan+Park&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Park Sun-Whan</a></span>. Molecular genetic characterisation of norovirus GII.17 strains circulating in South Korea in 2024. <a href="/content/ecdc">Euro Surveill.</a> 2026;31(13):pii=2500372. <a href="https://doi.org/10.2807/1560-7917.ES.2026.31.13.2500372" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2026.31.13.2500372</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 28 May 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 16 Sept 2025 </span> </p>
/content/10.2807/1560-7917.ES.2026.31.13.2500372
/content/10.2807/1560-7917.ES.2026.31.13.2500372
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error